Wall Street analysts expect Skyward Specialty Insurance (SKWD) to post quarterly earnings of $0.78 per share in its upcoming report, which indicates a year-over-year increase of 4%. Revenues are expected to be $311.37 million, up 17.5% from the year-ago quarter. Over the last 30 days, there has been a downward revision of 0.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. That said, let's delve into the average estimates of some Skyward metrics that Wall Street analysts commonly model and monitor. Analysts' assessment points toward 'Revenues- Net investment income' reaching $21.58 million. The estimate suggests a change of +18% year over year. It is projected by analysts that the 'Revenues- Net earned premiums' will reach $287.63 million. The estimate suggests a change of +21.7% year over year. The consensus among analysts is that 'Expense ratio' will reach 28.4%. The estimate is in contrast to the year-ago figure of 28.7%. Analysts expect 'Loss ratio' to come in at 63.2%. Compared to the present estimate, the company reported 60.9% in the same quarter last year. The consensus estimate for 'Combined ratio' stands at 92.1%. Compared to the current estimate, the company reported 89.6% in the same quarter of the previous year. View all Key Company Metrics for Skyward here>>> Over the past month, shares of Skyward have returned +0.1% versus the Zacks S&P 500 composite's -0.8% change. Currently, SKWD carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues Skyward Specialty Insurance Group, Inc. (SKWD):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Gear Up for Skyward (SKWD) Q1 Earnings: Wall Street Estimates for Key Metrics
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...